Abstract
The biological property of an antibody is determined by its antigen binding characteristics and its isotype-related effector functions. We have established monoclonal antibodies of different isotypes by stepwise selection and cloning of the hybridoma CE7. The original CE7 secretes an IgG1/kappa (CE7 gamma 1) antibody that recognises a 185 kD cell surface glycoprotein expressed on all human sympatho-adrenomedullary cells. Isotype-switch variants were isolated in the following sequence: from the original CE7 gamma 1, CE7 gamma 2b variants were isolated, and from a CE7 gamma 2b variant CE7 gamma 2a variants were isolated. The antibodies of three different isotype variant cell lines possess identical antigen binding characteristics, but display distinct effector functions as demonstrated by antibody dependent cell-mediated cytotoxicity (ADCC). ADCC was performed with the neuroblastoma line IMR-32 as the target cells, and different FcR gamma positive cells were either freshly isolated from human peripheral blood leukocytes or cultured for 6-10 days and tested as potential effector cells. Tumour lysis mediated by monocyte-derived macrophages depended on the presence of CE7 gamma 2a antibodies; antibodies from the CE7 hybridomas of gamma 2b and gamma 1 isotypes were virtually inactive in ADCC assay. Pre-exposure of macrophages to rIFN-gamma enhanced their ADCC activity, a result that is compatible with the notion that the high affinity Fc IgG receptor (FcR gamma I/CD64) is involved in the triggering of ADCC in macrophages. In contrast to macrophages, mononuclear cells, nonadherent cells and monocytes displayed considerable non-specific lytic activity, which was little influenced by the presence of antibody regardless of the isotype added.
Highlights
Human neuroblastomas can arise either during embryogenesis or post-natally from stem cells of the peripheral sympathetic nervous system
We report here that monoclonal CE7y2a antibodies trigger macrophage antibody dependent cell-mediated cytotoxicity (ADCC), while CE7y2b and CE771 antibodies were ineffective
The parent hybridoma cell line CE7 producingyl/x antibody had been growing in culture for more than 3 months and the selected CE7'y2b hybridoma for1 month without subcloning
Summary
Human neuroblastomas can arise either during embryogenesis or post-natally from stem cells of the peripheral sympathetic nervous system. These tumours represent highly malignant solid neoplasms. They show various stages of development which are reflected by particular molecular structures on the cell surface (Hughes et al, 1974; Evans et al, 1976; Momoi et al, 1980). The phenotype of neuroblastoma can be identified using a panel of monoclonal antibodies (MAb) specific for various cell surface molecules expressed at different stages of development (Kemshead & Black, 1980; Kemshead et al, 1983; Schonmann et al, 1986)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
